Home
Conditions
Hypersensitivity, Immediate

Clinical trial condition

Hypersensitivity, Immediate

Explore clinical trials studying Hypersensitivity, Immediate. Study availability and eligibility vary by location and protocol.

6,714 public trials 622 recruiting studies

Refine in advanced search Browse all conditions

Hypersensitivity, Immediate trial results

Completed

C1-Esteraseremmer-N for the Treatment of Hereditary (and Acquired) Angioedema

NCT00125151

Conditions: Acquired angioedema, Angioedema, Angioedemas, Hereditary, +10 more
Locations: Academic Medical Centre Amsterdam, Netherlands

Academic hospital Groningen Groningen, Netherlands

Erasmus Medical Centre Rotterdam, Netherlands

View Trial Details

Completed

Kinetics, Efficacy and Safety of C1-Esteraseremmer-N

NCT00119431

Conditions: Angioedema, Angioedemas, Hereditary, Angioneurotic Edema, +11 more
Locations: Academic Medical Centre Amsterdam, Netherlands

Erasmus Medical Centre Rotterdam, Netherlands

View Trial Details

Completed

C1-Esteraseremmer-N for the Treatment of Hereditary (and Acquired) Angioedema

NCT00125541

Conditions: Acquired angioedema, Angioedema, Angioedemas, Hereditary, +10 more
Locations: Academic Medical Centre Amsterdam, Netherlands

View Trial Details

Completed

Safety and Tolerability Study of rBet v1 SLIT Tablets

NCT00889460

Conditions: Birch Pollen-Related Rhinoconjunctivitis, Hypersensitivity, Hypersensitivity, Immediate, +8 more
Locations: National University Hospital - Allergy Unit 4222 Copenhagen, Denmark

View Trial Details

Completed

A Study to Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivitis

NCT00574223

Conditions: Dust Mite Allergy, House Dust Mite Allergy, Hypersensitivity, +10 more
Locations: Cytos Biotechnology (Sponsor's Headquarter) Schlieren, Switzerland

View Trial Details

Completed

Evaluation of Efficacy and Safety of an Anti-Allergy Drug With a Contact Lens in the Treatment of Allergic Conjunctivitis

NCT00445874

Conditions: Allergic Conjunctivitis, Conjunctival Diseases, Conjunctivitis, +5 more
Locations: Phoenix, Arizona, United States

Phoenix, Arizona, United States

Irvine, California, United States

North Andover, Massachusetts, United States

View Trial Details

Completed

Evaluation of Efficacy and Safety of an Anti-Allergy Drug With a Contact Lens in Allergic Conjunctivitis

NCT00432757

Conditions: Allergic Conjunctivitis, Conjunctival Diseases, Conjunctivitis, +5 more
Locations: Los Angeles, California, United States

Charlotte, North Carolina, United States

Memphis, Tennessee, United States

View Trial Details

Completed

Dyspnea and Biomarkers in a Prehospital Setting

NCT00878475

Conditions: Asthma, Bronchial Diseases, COPD, +19 more
Locations: Health Center Maribor, Center for Emergency Medicine Maribor, Slovenia

View Trial Details

Completed

Efficacy of Ciclesonide Versus Placebo Administered Either as Once Daily or Twice Daily in Patients Treated Previously With an Inhaled Corticosteroid

NCT00174733

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: Sanofi-Aventis Bridgewater, New Jersey, United States

View Trial Details

Completed

Efficacy of Ciclesonide vs Placebo Administered as Once Daily or Twice Daily in Patients Not Treated With Inhaled Corticosteroid.

NCT00174720

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: Sanofi-Aventis Administrative Office Bridgewater, New Jersey, United States

Sanofi-Aventis Administrative Office São Paulo, Brazil

Sanofi-Aventis Administrative Office Santiago, Chile

Sanofi-Aventis Administrative Office San José, Costa Rica

View Trial Details

Hypersensitivity, Immediate

Hypersensitivity, Immediate trial results

Related conditions